Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2009 - 2026)

Zimmer Biomet Holdings' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $22.7 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 2.42% year-over-year to $22.7 billion; the TTM figure through Mar 2026 stood at $92.2 billion (up 6.2% YoY), while the FY2025 annual figure was $23.1 billion, up 8.08% from the prior year.
• Liabilities and Shareholders Equity was $22.7 billion for Q1 2026 at Zimmer Biomet Holdings, down from $23.1 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $23.5 billion in Q3 2025 to a low of $21.1 billion in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $21.8 billion across 5 years, with a median of $21.5 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity fell 11.44% in 2022, then rose 8.14% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $21.1 billion in 2022, then increased by 2.05% to $21.5 billion in 2023, then decreased by 0.61% to $21.4 billion in 2024, then gained by 8.08% to $23.1 billion in 2025, then slipped by 1.6% to $22.7 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $22.7 billion (Q1 2026), $23.1 billion (Q4 2025), and $23.5 billion (Q3 2025), per Business Quant data.